Dividend-adjusted total return · S&P 500 uses VOO · Oct 30, 2023 – Nov 4, 2026FHLCS&P 500 · VOO
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | +3.1% | +12.3% | +14.0% | +23.4% | +32.2% | +63.8% | +48.9% | +336.8% |
| Peer average | +2.7% | +8.5% | +8.9% | +24.4% | +33.4% | +84.3% | +34.0% | — |
| S&P 500 · VOO | +1.6% | −1.6% | 0.0% | +13.4% | +13.5% | +91.7% | +81.2% | — |
Key Statistics
Open all fund facts →- AUM
- $3.5B
- Expense ratio
- 0.08%
- Distribution yield
- 1.1%
- NAV
- $88.08
- Volume
- 453K
- Avg. volume 30D
- 286K
- High today
- $91.03
- Low today
- $88.66
- Previous close
- $88.06
- 52-week high
- $91.03
- 52-week low
- $68.46
- Our risk indicator
- 4/5
FHLC in One Breath
FHLC Among Health Care ETFs
YTDEnd-of-day Nov 5, 2026 · 33 Health care ETFs by YTD
$10,000 in FHLC
5Y$10,000 in FHLC became
$14,895
In the S&P 500 (VOO)
$18,115
Total return, dividends in · Oct 27, 2021 – Nov 4, 2026 · S&P 500 uses VOO
FHLC’s Top Holdings
TodayLLYEli Lilly &14.6%JNJ8.3%ABBV6.5%UNH4.8%MRK4.6%TMO3.4%AMGN3.2%GILD2.7%ABT2.5%PFE2.2%ISRG2.0%DHR1.9%VRTX1.7%0Y6X.L1.6%BMY1.6%MCK1.5%CVS1.5%SYK1.4%REGN1.3%ANTM1.2%CI1.0%MRNA1.0%343 more
LLYEli Lilly &14.6%JNJ8.3%ABBV6.5%UNH4.8%MRK4.6%TMO3.4%AMGN3.2%GILD2.7%ABT2.5%PFE2.2%ISRGDHR353 more
Drug Manufacturers - GeneralMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyMedical - InstrumentsOther
Fidelity FHLC · 365 holdings · tile size = share of the fund · as of Nov 4, 2026
What FHLC Holds
TodayDrug Manufacturers - General44.3%
LLY 14.6 · JNJ 8.3 · ABBV 6.5 · MRK 4.6 · AMGN 3.2 · GILD 2.7 · PFE 2.2
Medical - Diagnostics & Research11.0%
TMO 3.4 · DHR 1.9 · IDXX · NTRA · A · WAT · IQV
Medical - Healthcare Plans9.7%
UNH 4.8 · CVS 1.5 · ANTM 1.2 · CI 1.0 · HUM · CNC · MOH
Medical - Devices9.0%
ABT 2.5 · 0Y6X.L 1.6 · SYK 1.4 · BSX · EW · GEHC · DXCM
Biotechnology7.5%
VRTX 1.7 · REGN 1.3 · MRNA · RVMD · UTHR · INSM · ALNY
Medical - Instruments & Supplies4.4%
ISRG 2.0 · BDX · RMD · WST · BAX · MDLN · SOLV
Other holdings14.1%
MCK 1.5 · HCA · COR · CAH · VEEV · ZTS · RPRX
Fidelity FHLC · share of the fund by industry · as of Nov 4, 2026
Eli’s Share of FHLC
Today14.6%
$146 of every $1,000 in FHLC is Eli
Eli held by FHLC
$517M
Fidelity FHLC · each square = $10 of $1,000 · as of Nov 4, 2026
FHLC’s Share of Health Care ETFs
Today3.2%
of the $109B in 39 Health care ETFs
$3.5B3.2%
$49.1B45.0%
$19.1B17.5%
$37.3B34.2%
Health care ETF AUM · Nov 5, 2026
FHLC Fee per $100 vs Peers
TodayExpense ratio · Health care peers · Nov 5, 2026
Inside FHLC
365 holdings · as of Nov 4, 2026FHLC
Fidelity MSCI Health Care Index ETF
TodayDrug Manufacturers - General44.3%LLYELI Lilly &14.6%JNJ8.3%ABBV6.5%MRK4.6%AMGN3.2%GILD2.7%PFEBMYMedical - Diagnostics11.0%TMO3.4%DHR1.9%IDXXNTRAAWATIQVLHDGXMedical - Healthcare Plans9.7%UNH4.8%CVSANTMCIHUMCNCMedical - Devices9.0%ABT2.5%SYKBSXEWGEHCDXCMBiotechnology7.5%VRTX1.7%REGNMRNARVMDMedical - Instruments4.4%ISRGBDXOther14.1%MCKHCACORCAHVEEVZTSRPRX11 more
Drug Manufacturers - General44.3%LLY14.6%JNJ8.3%ABBV6.5%MRK4.6%AMGNGILD3 moreMedical - Diagnostics11.0%TMO3.4%DHRIDXXNTRAAWAT9 moreMedical - Healthcare Plans9.7%UNH4.8%CVSANTMCIHUMCNCMedical - Devices9.0%ABTSYKEWGEHCBiotechnology7.5%VRTXREGNMRNA16 moreMedical - Instruments4.4%ISRGBDXOther14.1%MCKHCACOR15 more
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 14.61% |
| 2 | JNJ | Johnson & Johnson | 8.30% |
| 3 | ABBV | Abbvie | 6.55% |
| 4 | UNH | Unitedhealth Group | 4.76% |
| 5 | MRK | Merck & NEW | 4.63% |
| 6 | TMO | Thermo Fisher Scientific | 3.36% |
| 7 | AMGN | Amgen | 3.22% |
| 8 | GILD | Gilead Sciences | 2.69% |
| 9 | ABT | Abbott Laboratories | 2.47% |
| 10 | PFE | Pfizer | 2.21% |
Drug Manufacturers - GeneralMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyMedical - InstrumentsOther
Fidelity FHLC · current holdings by weight · as of Nov 4, 2026 · each tile is one holding · top 20 = 68.6%
How It Compares
FHLC
Fidelity MSCI Health Care Index ETF’s Peers
YTDHealth care peers · YTD and past-year returns · as of Nov 5, 2026 · sorted by AUM
Head to Head
Put FHLC head to head with XLV →XLV vs FHLC
YTDYear to date
XLV wins+0.6 pts
Past year
XLV wins+1.3 pts
Fee
Level
Yield
XLV wins+0.2 pts
AUM
XLV13.9× more
3–0XLV wins
SPDR XLV and Fidelity FHLC · year-to-date · as of Nov 5, 2026 · AUM not scored
FHLC vs VOO
YTDFHLC · Fidelity MSCI Health Care Index
+23.4%
VOO · S&P 500
+13.4%
Gap
10.1 pts
Fidelity FHLC and Vanguard VOO · YTD total return · as of Nov 5, 2026
FHLC vs Its Peer Average
YTDFHLCAvsBPeer average
1D+3.1%+2.7%
1M+12.3%+8.5%
3M+14.0%+8.9%
YTD+23.4%+24.4%
1Y+32.2%+33.4%
3Y+63.8%+84.3%
5Y+48.9%+34.0%
4–3FHLC wins
38 Health care peers · each row scaled to its leader
The Details
FHLC
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y16.08%
Deepest drop · 1Y−10.4%
Lowest point · 5Y−11.6%
52-week range
$90.77
$68.46−0.3% from the high$91.03
Fidelity FHLC · past-year price moves · as of Nov 5, 2026
FHLC
Fund Facts
Today2013launched Oct 21
Tracks[…]
Exchange · CUSIPAMEX · 316092600
StructureETF
Leverage1x
Cost on $10,000$8 a year
Go deeper
Fidelity FHLC · fund facts · as of Nov 5, 2026
FHLC
Payouts by Year
13Y$0.25per share, Sep 2026
Distribution yield1.1%
PaidEvery quarter
Latest ex-date · paidSep 18 · Sep 22, 2026
12 payouts added up$3.00 a share
Fidelity FHLC · distributions by ex-date · 2014–2026
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-07-31 ↗SEC reported portfolio · 2026-04-30 ↗SEC reported portfolio · 2026-01-31 ↗SEC reported portfolio · 2025-10-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-07-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-04-30 ↗SEC reported portfolio · 2025-01-31 ↗SEC reported portfolio · 2024-10-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-07-31 ↗SEC reported portfolio · 2024-04-30 ↗SEC reported portfolio · 2024-01-31 ↗
Trading & Liquidity
Net asset value$88.08
Premium / discount[…]
Median spread · 30D[…]
Volume today453K
Average volume · 30D286K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.08%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$8.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 18, 2026 | Sep 22, 2026 | $0.25 |
| Jun 18, 2026 | Jun 23, 2026 | $0.26 |
| Mar 20, 2026 | Mar 24, 2026 | $0.23 |
| Dec 19, 2025 | Dec 23, 2025 | $0.27 |
| Sep 19, 2025 | Sep 23, 2025 | $0.26 |
| Jun 20, 2025 | Jun 24, 2025 | $0.26 |
| Mar 21, 2025 | Mar 25, 2025 | $0.25 |
| Dec 20, 2024 | Dec 24, 2024 | $0.26 |
| Sep 20, 2024 | Sep 24, 2024 | $0.25 |
| Jun 21, 2024 | Jun 25, 2024 | $0.24 |
| Mar 15, 2024 | Mar 20, 2024 | $0.24 |
| Dec 15, 2023 | Dec 20, 2023 | $0.22 |
Issuer contentFrom FidelityHear the strategy from the people behind FHLC.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →